The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
After years relying on the U.S. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. Jynneos, the only FDA-approved mpox ...
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
Bavarian Nordic’s Jynneos, the only FDA-approved vaccine for mpox, recently made headway into the US commercial market.
Research suggests booster doses may be necessary for monkeypox immunity ... In contrast, for previously vaccinated individuals, the median titer 28 days after a single dose of the MVA-BN vaccine ...
Mpox, formally known as Monkeypox, cases are on the rise, CDC says. Mpox, formerly known as monkeypox, cases are on the rise here in the U.S., with nearly double the number of infections compared ...
Vaccine protection against mpox fades quickly in the human immune system, even in people who've received the full two-dose regimen, a new real-world study shows. Antibody levels fell to low or ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
Tens of thousands of Brits were jabbed against the virus — previously known as monkeypox — after an outbreak in the summer 2022. But immunity from the vaccine may already be at zero, Swedish ...
A regulatory decision is expected on February 14, 2025. The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) ...
, opens new tab diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand, the U.S. Food and Drug ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...